.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Farmers Insurance
Johnson and Johnson
Express Scripts
UBS
McKinsey
Fish and Richardson
Deloitte
Merck

Generated: November 21, 2017

DrugPatentWatch Database Preview

Nascobal Drug Profile

« Back to Dashboard

Which patents cover Nascobal, and what generic Nascobal alternatives are available?

Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Pharmacology for Nascobal

Ingredient-typeVitamin B 12
Drug ClassVitamin B12
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
NASCOBAL
cyanocobalamin
GEL, METERED;NASAL019722-001Nov 5, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► SubscribeY ► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► Subscribe ► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► SubscribeY ► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► SubscribeY ► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► Subscribe ► Subscribe
Endo Pharms Inc
NASCOBAL
cyanocobalamin
SPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NASCOBAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm
NASCOBAL
cyanocobalamin
GEL, METERED;NASAL019722-001Nov 5, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for NASCOBAL

Drugname Dosage Strength RLD Submissiondate
cyanocobalaminNasal Spray500 mcg/sprayNascobal4/28/2017
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Fish and Richardson
Cerilliant
Fuji
QuintilesIMS
Dow
McKinsey
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot